The pharmacological profile of dienogest
M. Öettel(Jena Bioscience (Germany)), H. Zimmermann(Jena Bioscience (Germany)), Vladimir K. Patchev(Max Planck Institute of Psychiatry), Lothar Sobek(Jena Bioscience (Germany)), H Breitbarth(Jena Bioscience (Germany)), W. Elger(Jena Bioscience (Germany)), C. Moore(Jena Bioscience (Germany)), T Gräser(Jena Bioscience (Germany)), G. Kaufmann(Jena Bioscience (Germany)), Wolfgang Römer(Jena Bioscience (Germany)), J. M. Schröder(Maastricht University), Doris Hübler(Jena Bioscience (Germany))
The European Journal of Contraception & Reproductive Health Care
January 1, 1999
Cited by 62
Related Papers
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k
Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy
|Nature Genetics|2005|251
Mutations in a Gene Encoding a Novel SH3/TPR Domain Protein Cause Autosomal Recessive Charcot-Marie-Tooth Type 4C Neuropathy
|The American Journal of Human Genetics|2003|213
Hereditary Motor and Sensory Neuropathies
|Unknown|2001|175